GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript
GeoVax Labs, Inc. is focusing on building a resilient infectious disease preparedness strategy. The company is targeting diseases such as Ebola, Marburg, Hantavirus, and Mpox through its vaccine development efforts. This initiative aims to enhance public health responses to high-consequence infectious diseases.
- ▪GeoVax Labs, Inc. is a clinical stage biotechnology company.
- ▪The company is developing vaccines and immunotherapies for infectious diseases and solid tumor cancers.
- ▪GeoVax's priority program is a modified vaccinia Ankara MVA-based vaccine targeting Mpox.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4909813-geovax-labs-inc-govx-discusses-building-a-resilient-infectious-disease-preparedness-strategy"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
